Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
The AAPS Journal|June 4, 2011
Examination of the pharmacokinetics of active ingredients of ginger in humansYanke Yu, Suzanna Zick, Xiaoqin Li, et al.
Journal of Hazardous Materials|September 14, 2019
Non-thermal plasma coupled with MOF-74 derived Mn-Co-Ni-O porous composite oxide for toluene efficient degradationXiangbo Feng, Changwei Chen, Chi He, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2020
Palbociclib (PD-0332991) pharmacokinetics in subjects with impaired renal functionYanke Yu, Justin Hoffman, Anna Plotka, et al.
The Journal of Biological Chemistry|October 28, 2009
Characterization of celastrol to inhibit hsp90 and cdc37 interactionTao Zhang, Yanyan Li, Yanke Yu, et al.
Environmental Technology|September 2, 2015
Deactivation mechanism and feasible regeneration approaches for the used commercial NH3-SCR catalystsYanke Yu, Xiaoran Meng, Jinsheng Chen, et al.
International Journal of Pharmaceutics|January 15, 2013
Characterization of the pharmacokinetics of a liposomal formulation of eribulin mesylate (E7389) in miceYanke Yu, Christopher Desjardins, Phil Saxton, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 14, 2006
A comparative study of using comet assay and gammaH2AX foci formation in the detection of N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA damageYanke Yu, Wen Zhu, Huiling Diao, et al.
Journal of Environmental Sciences (China)|March 17, 2020
Effects of calcination temperature on physicochemical property and activity of CuSO4/TiO2 ammonia-selective catalytic reduction catalystsYanke Yu, Jiali Zhang, Changwei Chen, et al.
Targeted Oncology|November 19, 2020
Impact of Dose Reduction on Efficacy: Implications of Exposure-Response Analysis of PalbociclibJenny Zheng, Yanke Yu, Chandrasekar Durairaj, et al.
Pageof 6